MythBusting: 6 eConsent Myths We Need to Correct in 2018.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 22
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2018 AND VI 27 AND IP 4
Results: 10
1
2
The Impetus for Natural History Studies in Rare Disease R&D: The use of natural history (NH) studies early in clinical research can help facilitate development programs for orphan drugs.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 18
- By:
- Publication type:
- Article
3
10 Barriers and Solutions to Smart Clinical Program Designs: How the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information".
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 10
- By:
- Publication type:
- Article
4
LILLY JOINS FORCE ON CLINICAL TRIAL PATIENT EDUCATION.
- Published in:
- 2018
- By:
- Publication type:
- Interview
5
PATIENT INPUT INTO LEVERAGING THE HEALTHCARE PROFESSIONAL'S ROLE.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 6
- By:
- Publication type:
- Article
6
FDA NOTES.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 5
- Publication type:
- Article
7
LEADING CROS FORM NEW INDUSTRY STANDARDS GROUP.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 4
- Publication type:
- Article
8
THE COMMEDIA DELL'ARTE OF THE EMA RELOCATION.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 4
- By:
- Publication type:
- Article
9
All in Our Heads? The Power of Placebo Response.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 2
- By:
- Publication type:
- Article
10
THE PULL AND TUG ON ORPHAN DRUG DEVELOPMENT.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 4, p. 5
- By:
- Publication type:
- Article